XenoTherapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Debt - Acquisition
  • (Announced)

  • Investors
  • 4

XenoTherapeutics General Information

Description

Operator of a biotechnology research and development company intended to further the advancement of the science of xenotransplantation through education, research, development, and clinical testing. The company focuses on product discovery and testing to de-risk and optimize therapeutic candidates while decreasing the time to market, enabling medical researchers to get access to an affordable, safe, and plentiful treatment whenever necessary.

Contact Information

Website
www.xenotx.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Greater Boston Area
  • Boston, MA
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Greater Boston Area
  • Boston, MA
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XenoTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - Acquisition 14-Jul-2025 Announced Clinical Trials - General
4. Later Stage VC (Series A) 17-May-2021 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2018 Completed Startup
2. Grant 27-Jan-2017 $10K Completed Clinical Trials - General
1. Accelerator/Incubator 19-May-2016 Completed Startup
To view XenoTherapeutics’s complete valuation and funding history, request access »

XenoTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology research and development company intended to further the advancement of the science of xenot
Drug Discovery
Boston, MA
10 As of 2025

New York, NY
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XenoTherapeutics Competitors (4)

One of XenoTherapeutics’s 4 competitors is ITB-Med, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ITB-Med Venture Capital-Backed New York, NY
Egenesis Venture Capital-Backed Cambridge, MA
ProKidney Corporation Winston-Salem, NC
United Therapeutics Formerly VC-backed Silver Spring, MD
To view XenoTherapeutics’s complete competitors history, request access »

XenoTherapeutics Patents

XenoTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022256401-A1 Xenogeneic nerve transplants and methods Inactive 01-Jun-2021
US-20260114433-A1 Humanization of beta2-microglobulin in porcine genome resulting in functional expression of human beta2-microglobulin within donor cells, tissues, or organs Inactive 16-Dec-2020
WO-2022133155-A1 Humanization of beta2-microglobulin in porcine genome resulting in functional expression of human βeta2-microglobulin within donor cells, tissues, or organs Inactive 16-Dec-2020
AU-2021333671-A1 Immunologically compatible cells, tissues, organs, and methods for transplantation for silencing, humanization, and personalization with minimized collateral genomic disruptions Inactive 24-Aug-2020
AU-2021333671-A9 Immunologically compatible cells, tissues, organs, and methods for transplantation for silencing, humanization, and personalization with minimized collateral genomic disruptions Inactive 24-Aug-2020 A01K67/0275
To view XenoTherapeutics’s complete patent history, request access »

XenoTherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XenoTherapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Varana Capital PE/Buyout Minority
Mass Innovation Network Accelerator/Incubator
John Flatley Company Corporation
MassChallenge Accelerator/Incubator
To view XenoTherapeutics’s complete investors history, request access »

XenoTherapeutics Acquisitions (2)

XenoTherapeutics’s most recent deal was a Merger/Acquisition with Repare Therapeutics for . The deal was made on 28-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Repare Therapeutics 28-Jan-2026 Merger/Acquisition Drug Discovery
ESSA Pharma 09-Oct-2025 Merger/Acquisition Drug Discovery
To view XenoTherapeutics’s complete acquisitions history, request access »

XenoTherapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Repare Therapeutics Saint-Laurent, Canada 2016

XenoTherapeutics FAQs

  • When was XenoTherapeutics founded?

    XenoTherapeutics was founded in 2016.

  • Where is XenoTherapeutics headquartered?

    XenoTherapeutics is headquartered in Boston, MA.

  • What is the size of XenoTherapeutics?

    XenoTherapeutics has 10 total employees.

  • What industry is XenoTherapeutics in?

    XenoTherapeutics’s primary industry is Drug Discovery.

  • Is XenoTherapeutics a private or public company?

    XenoTherapeutics is a Private company.

  • What is XenoTherapeutics’s current revenue?

    The current revenue for XenoTherapeutics is .

  • Who are XenoTherapeutics’s investors?

    Varana Capital, Mass Innovation Network, John Flatley Company, and MassChallenge have invested in XenoTherapeutics.

  • Who are XenoTherapeutics’s competitors?

    ITB-Med, Egenesis, ProKidney, and United Therapeutics are competitors of XenoTherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process